SUPERBUG: The Quest for Drug Developers
February 28, 2013
The incidences of drug resistant strains are becoming more and more common while many manufacturers have stepped back on the antibiotic development. These two factors have created a situation that has almost sent patients and physicians back to the pre-antibiotic era. Join Maryn McKenna author of Superbug as she explores the history and rise of multi-drug resistant MRSA.
*Access to this recording is an exclusive benefit for ACS Members.
What You Will Learn
- Review the rise of multi-drug resistant MRSA and CRE
- Understand the complexities of MDROs in healthcare
- Review the decline in antimicrobial development
- Explore the structure of possible incentives to encourage new drugs
- And much more…
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.